JW Pharmaceutical Corp Net Asset Quality Index
JW Pharmaceutical Corp net asset quality index. JW Pharmaceutical Corp (001067) has a Net Asset Quality Index of 57.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩611.56 Billion minus total liabilities of ₩257.46 Billion yields net assets of ₩354.10 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See JW Pharmaceutical Corp net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of JW Pharmaceutical Corp (2014–2024)
Net asset quality index of JW Pharmaceutical Corp from 2014 to 2024. This chart shows how JW Pharmaceutical Corp's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 57.9%, representing net assets of ₩354.10 Billion against total assets of ₩611.56 Billion KRW. Check how strategically is JW Pharmaceutical Corp's equity deployed to assess the company's strategic physical and investment asset allocation.
JW Pharmaceutical Corp Net Asset Quality Index by Year (2014–2024)
JW Pharmaceutical Corp net asset quality index by year from 2014 to 2024. The table below presents the year-by-year Net Asset Quality Index for JW Pharmaceutical Corp from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see JW Pharmaceutical Corp market cap and net worth.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 54.5% | ₩329.49 Billion | ₩604.60 Billion | ₩275.11 Billion | ▲ +13.3 pp |
| 2023 | 41.2% | ₩265.44 Billion | ₩645.04 Billion | ₩379.60 Billion | ▲ +5.2 pp |
| 2022 | 36.0% | ₩225.76 Billion | ₩627.97 Billion | ₩402.21 Billion | ▲ +6.2 pp |
| 2021 | 29.8% | ₩188.54 Billion | ₩633.05 Billion | ₩444.51 Billion | ▼ -8.0 pp |
| 2020 | 37.8% | ₩207.47 Billion | ₩549.09 Billion | ₩341.62 Billion | ▼ -2.4 pp |
| 2019 | 40.1% | ₩230.09 Billion | ₩573.21 Billion | ₩343.12 Billion | ▼ -3.7 pp |
| 2018 | 43.8% | ₩260.11 Billion | ₩593.79 Billion | ₩333.68 Billion | ▲ +0.9 pp |
| 2017 | 42.9% | ₩270.78 Billion | ₩630.87 Billion | ₩360.10 Billion | ▲ +0.5 pp |
| 2016 | 42.4% | ₩276.31 Billion | ₩651.08 Billion | ₩374.76 Billion | ▲ +5.7 pp |
| 2015 | 36.7% | ₩225.41 Billion | ₩613.48 Billion | ₩388.07 Billion | ▼ -0.6 pp |
| 2014 | 37.3% | ₩220.02 Billion | ₩589.24 Billion | ₩369.22 Billion | — |